These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 15658866

  • 1. Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.
    Grace CR, Durrer L, Koerber SC, Erchegyi J, Reubi JC, Rivier JE, Riek R.
    J Med Chem; 2005 Jan 27; 48(2):523-33. PubMed ID: 15658866
    [Abstract] [Full Text] [Related]

  • 2. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
    Grace CR, Koerber SC, Erchegyi J, Reubi JC, Rivier J, Riek R.
    J Med Chem; 2003 Dec 18; 46(26):5606-18. PubMed ID: 14667215
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides.
    Rivier JE, Kirby DA, Erchegyi J, Waser B, Eltschinger V, Cescato R, Reubi JC.
    J Med Chem; 2005 Jan 27; 48(2):515-22. PubMed ID: 15658865
    [Abstract] [Full Text] [Related]

  • 4. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J, Waser B, Schaer JC, Cescato R, Brazeau JF, Rivier J, Reubi JC.
    J Med Chem; 2003 Dec 18; 46(26):5597-605. PubMed ID: 14667214
    [Abstract] [Full Text] [Related]

  • 5. Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan.
    Erchegyi J, Hoeger CA, Low W, Hoyer D, Waser B, Eltschinger V, Schaer JC, Cescato R, Reubi JC, Rivier JE.
    J Med Chem; 2005 Jan 27; 48(2):507-14. PubMed ID: 15658864
    [Abstract] [Full Text] [Related]

  • 6. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J, Penke B, Simon L, Michaelson S, Wenger S, Waser B, Cescato R, Schaer JC, Reubi JC, Rivier J.
    J Med Chem; 2003 Dec 18; 46(26):5587-96. PubMed ID: 14667213
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. N-imidazolebenzyl-histidine substitution in somatostatin and in its octapeptide analogue modulates receptor selectivity and function.
    Erchegyi J, Cescato R, Waser B, Rivier JE, Reubi JC.
    J Med Chem; 2011 Sep 08; 54(17):5981-7. PubMed ID: 21806016
    [Abstract] [Full Text] [Related]

  • 11. Novel sst5-selective somatostatin dicarba-analogues: synthesis and conformation-affinity relationships.
    D'Addona D, Carotenuto A, Novellino E, Piccand V, Reubi JC, Di Cianni A, Gori F, Papini AM, Ginanneschi M.
    J Med Chem; 2008 Feb 14; 51(3):512-20. PubMed ID: 18210999
    [Abstract] [Full Text] [Related]

  • 12. Cyclic retro-inverso dipeptides with two aromatic side chains. II. Conformational analysis.
    Yamazaki T, Nunami K, Goodman M.
    Biopolymers; 1991 Nov 14; 31(13):1513-28. PubMed ID: 1814501
    [Abstract] [Full Text] [Related]

  • 13. Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues.
    Erchegyi J, Cescato R, Grace CR, Waser B, Piccand V, Hoyer D, Riek R, Rivier JE, Reubi JC.
    J Med Chem; 2009 May 14; 52(9):2733-46. PubMed ID: 19351180
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Highly potent cyclic disulfide antagonists of somatostatin.
    Hocart SJ, Jain R, Murphy WA, Taylor JE, Coy DH.
    J Med Chem; 1999 Jun 03; 42(11):1863-71. PubMed ID: 10354394
    [Abstract] [Full Text] [Related]

  • 16. Replacement of Phe6, Phe7, and Phe11 of D-Trp8-somatostatin-14 with L-pyrazinylalanine. Predicted and observed effects on binding affinities at hSST2 and hSST4. An unexpected effect of the chirality of Trp8 on NMR spectra in methanol.
    Neelamkavil S, Arison B, Birzin E, Feng JJ, Chen KH, Lin A, Cheng FC, Taylor L, Thornton ER, Smith AB, Hirschmann R.
    J Med Chem; 2005 Jun 16; 48(12):4025-30. PubMed ID: 15943475
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
    Sukopp M, Schwab R, Marinelli L, Biron E, Heller M, Várkondi E, Pap A, Novellino E, Kéri G, Kessler H.
    J Med Chem; 2005 Apr 21; 48(8):2916-26. PubMed ID: 15828830
    [Abstract] [Full Text] [Related]

  • 18. Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors.
    Nikiforovich GV, Marshall GR, Achilefu S.
    Chem Biol Drug Des; 2007 Mar 21; 69(3):163-9. PubMed ID: 17441902
    [Abstract] [Full Text] [Related]

  • 19. Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.
    Grace CR, Erchegyi J, Koerber SC, Reubi JC, Rivier J, Riek R.
    J Med Chem; 2006 Jul 27; 49(15):4487-96. PubMed ID: 16854054
    [Abstract] [Full Text] [Related]

  • 20. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.
    Prasad V, Birzin ET, McVaugh CT, Van Rijn RD, Rohrer SP, Chicchi G, Underwood DJ, Thornton ER, Smith AB, Hirschmann R.
    J Med Chem; 2003 May 08; 46(10):1858-69. PubMed ID: 12723949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.